Dopamine Effect on Inhibitory Control

NCT03665493 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Parkinson's Disease

Interventions

DRUG: PD patients H&Y=1.5-2 Medications ON
DRUG: PD patients H&Y=1.5-2 Medications OFF
BEHAVIORAL: Healthy age-matched controls
DRUG: PD patients H&Y=3 Medications OFF
DRUG: PD patients H&Y=3 Medications ON

Sponsor

Giovanni Mirabella